메뉴 건너뛰기




Volumn 23, Issue 5, 2014, Pages 1157-1163

Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: Results from the China National Stroke Registry

Author keywords

Anticoagulation; atrial fibrillation; stroke management; transient ischemic attack; warfarin

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN; ANTICOAGULANT AGENT;

EID: 84901377479     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.10.006     Document Type: Article
Times cited : (62)

References (21)
  • 1
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • P. Wolf, R. Abbott, and W. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.1    Abbott, R.2    Kannel, W.3
  • 2
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 323 1990 1505 1511
    • (1990) N Engl J Med , vol.323 , pp. 1505-1511
  • 3
    • 0026478818 scopus 로고
    • Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
    • M.D. Ezekowitz, S.L. Bridgers, and K.E. James et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
    • (1992) N Engl J Med , vol.327 , pp. 1406-1412
    • Ezekowitz, M.D.1    Bridgers, S.L.2    James, K.E.3
  • 4
    • 77953851760 scopus 로고    scopus 로고
    • Underuse of oral anticoagulants in atrial fibrillation: A systematic review
    • I.M. Ogilvie, N. Newton, and S.A. Welner et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638 645.e634
    • (2010) Am J Med , vol.123
    • Ogilvie, I.M.1    Newton, N.2    Welner, S.A.3
  • 5
    • 79451472118 scopus 로고    scopus 로고
    • Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation
    • C.J. Mercaldi, M. Ciarametaro, and B. Hahn et al. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation Stroke 42 2011 112 118
    • (2011) Stroke , vol.42 , pp. 112-118
    • Mercaldi, C.J.1    Ciarametaro, M.2    Hahn, B.3
  • 6
    • 16644399808 scopus 로고    scopus 로고
    • An epidemiological survey of atrial fibrillation in China
    • Z.Q. Zhou, D.Y. Hu, and J. Chen et al. An epidemiological survey of atrial fibrillation in China Chin J Intern Med 43 2004 491 494
    • (2004) Chin J Intern Med , vol.43 , pp. 491-494
    • Zhou, Z.Q.1    Hu, D.Y.2    Chen, J.3
  • 7
    • 84901339832 scopus 로고    scopus 로고
    • Retrospective investigation of hospitalized patients with atrial fibrillation in major parts of China
    • W.H. Qi Retrospective investigation of hospitalized patients with atrial fibrillation in major parts of China Chin J Cardiol 31 2003 913 915
    • (2003) Chin J Cardiol , vol.31 , pp. 913-915
    • Qi, W.H.1
  • 8
    • 79960267205 scopus 로고    scopus 로고
    • The China National Stroke Registry for patients with acute cerebrovascular events: Design, rationale, and baseline patient characteristics
    • Y. Wang, L. Cui, and X. Ji et al. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics Int J Stroke 6 2011 355 361
    • (2011) Int J Stroke , vol.6 , pp. 355-361
    • Wang, Y.1    Cui, L.2    Ji, X.3
  • 9
    • 84901374304 scopus 로고    scopus 로고
    • Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation
    • S. Li, X. Zhao, and C. Wang et al. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation J Stroke Cerebrovasc Dis 13 2013 146 148
    • (2013) J Stroke Cerebrovasc Dis , vol.13 , pp. 146-148
    • Li, S.1    Zhao, X.2    Wang, C.3
  • 10
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • B.F. Gage, A.D. Waterman, and W. Shannon et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3
  • 11
    • 60549096887 scopus 로고    scopus 로고
    • Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated
    • D.J. Gladstone, E. Bui, and J. Fang et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated Stroke 40 2009 235 240
    • (2009) Stroke , vol.40 , pp. 235-240
    • Gladstone, D.J.1    Bui, E.2    Fang, J.3
  • 12
    • 33644770242 scopus 로고    scopus 로고
    • Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice
    • L. Boulanger, J. Kim, and M. Friedman et al. Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice Int J Clin Pract 60 2006 258 264
    • (2006) Int J Clin Pract , vol.60 , pp. 258-264
    • Boulanger, L.1    Kim, J.2    Friedman, M.3
  • 13
    • 33845718250 scopus 로고    scopus 로고
    • Antithrombotic treatment in real-life atrial fibrillation patients: A report from the Euro Heart Survey on Atrial Fibrillation
    • R. Nieuwlaat, A. Capucci, and G.Y. Lip et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 2006 3018 3026
    • (2006) Eur Heart J , vol.27 , pp. 3018-3026
    • Nieuwlaat, R.1    Capucci, A.2    Lip, G.Y.3
  • 14
    • 54949116895 scopus 로고    scopus 로고
    • Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
    • 863.e2
    • S. Goto, D.L. Bhatt, and J. Rother et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Am Heart J 156 2008 855 863 863.e2
    • (2008) Am Heart J , vol.156 , pp. 855-863
    • Goto, S.1    Bhatt, D.L.2    Rother, J.3
  • 15
    • 70450248370 scopus 로고    scopus 로고
    • Warfarin versus aspirin: Using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation
    • S. Hopps, and T.R. Marcy Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation Consult Pharm 24 2009 841 844
    • (2009) Consult Pharm , vol.24 , pp. 841-844
    • Hopps, S.1    Marcy, T.R.2
  • 16
    • 77951154057 scopus 로고    scopus 로고
    • The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1
    • B.H. Lee, J.S. Park, and J.H. Park et al. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1 J Cardiovasc Electrophysiol 21 2010 501 507
    • (2010) J Cardiovasc Electrophysiol , vol.21 , pp. 501-507
    • Lee, B.H.1    Park, J.S.2    Park, J.H.3
  • 17
    • 0034627893 scopus 로고    scopus 로고
    • Why do patients with atrial fibrillation not receive warfarin?
    • T.J. Bungard, W.A. Ghali, and K.K. Teo et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
    • (2000) Arch Intern Med , vol.160 , pp. 41-46
    • Bungard, T.J.1    Ghali, W.A.2    Teo, K.K.3
  • 18
    • 34547992312 scopus 로고    scopus 로고
    • Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy
    • S.L. Partington, S. Abid, and K. Teo et al. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy Thromb Res 120 2007 663 669
    • (2007) Thromb Res , vol.120 , pp. 663-669
    • Partington, S.L.1    Abid, S.2    Teo, K.3
  • 19
    • 0037817710 scopus 로고    scopus 로고
    • Anticoagulant-related bleeding in older persons with atrial fibrillation: Physicians' fears often unfounded
    • M. Man-Son-Hing, and A. Laupacis Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded Arch Intern Med 163 2003 1580 1586
    • (2003) Arch Intern Med , vol.163 , pp. 1580-1586
    • Man-Son-Hing, M.1    Laupacis, A.2
  • 20
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial
    • J. Mant, F.D. Hobbs, and K. Fletcher et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.2    Fletcher, K.3
  • 21
    • 46049090018 scopus 로고    scopus 로고
    • The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • R.C. Becker, T.W. Meade, and P.B. Berger et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 776S 814S
    • (2008) Chest , vol.133
    • Becker, R.C.1    Meade, T.W.2    Berger, P.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.